JEWETT CAMERON (JCTC) 10% Owner AJB Investment Fund II Buys Shares

What Happened
AJB Investment Fund II, LP (a 10% owner of Jewett Cameron Trading Co. — ticker JCTC) reported open‑market purchases of common stock on July 29–30, 2026. Transactions: 1,000 shares @ $2.52 ($2,525), 155 shares @ $2.53 ($392), 423 shares @ $2.54 ($1,077), and 3,700 shares @ $2.60 ($9,635), for a total of 5,278 shares purchased for approximately $13,629. These were purchases (open‑market buys), which investors often view as a more informative signal than routine sales, though they do not prove intent.

Key Details

• Transaction dates and prices: 2026-07-29 — 1,000 @ $2.52; 155 @ $2.53; 423 @ $2.54. 2026-07-30 — 3,700 @ $2.60. Footnote reports a weighted average $2.604 and a price range $2.595–$2.6049.
• Total purchased: 5,278 shares for ~$13,629.
• Shares owned after transaction (aggregate beneficial ownership reported): 435,810 shares, including 343,630 shares held by AJB Investment Fund II, LP.
• Beneficial ownership notes: Adam J. Bradley may be deemed to beneficially own all 435,810 shares by virtue of direct ownership, control of AJB Capital, and investment discretion. Melinda Bradley may be deemed to beneficially own 390,066 shares (343,630 held by the fund + 46,436 in her IRA). Each reporting person disclaims ownership except to the extent of pecuniary interest.
• Filing timeliness: Form 4 filed on 2026-07-31 for trades on 7/29–7/30 — appears to be filed timely (within required reporting window).
• Nature of transaction: Open‑market purchases (transaction code P). No options, awards, or gifts reported.

Context
This filing reflects modest dollar purchases (~$13.6k) by a 10% institutional owner rather than an executive exercising options or receiving awards. The filing also shows overlapping reporting persons (Adam and Melinda Bradley) with control or investment discretion over various accounts; that explains the broader beneficial‑ownership figures. Transactions were routine open‑market buys — useful to note but not definitive evidence of future stock performance.